FIA
MRNA icon

FPC Investment Advisory’s Moderna MRNA Stock Holding History

FPC Investment Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$3.94K – 174
2024
Q4 		$3.94K Hold
100
– – ﹤0.01% 243
2024
Q3 		$5.87K Hold
100
– – 0.01% 49
2024
Q2 		$12.4K Hold
100
– – 0.01% 41
2024
Q1 		$10.9K Buy
+100
New +$10.1K 0.01% 38

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FPC Investment Advisory's MRNA Position: Q1 2025 in Review

FPC Investment Advisory sold out of Moderna (MRNA) in Q1 2025, closing a stake of 100 shares — an estimated $3.94K sold.

FPC Investment Advisory first reported a position in MRNA in Q1 2024 and held it in 4 quarters. The position peaked at $12.4K in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • FPC Investment Advisory reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • FPC Investment Advisory sold 100 Moderna shares in Q1 2025, an estimated $3.94K.
  • FPC Investment Advisory first reported a position in Moderna in Q1 2024 and held it in 4 quarters.
  • FPC Investment Advisory's Moderna position peaked at $12.4K in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on FPC Investment Advisory's 13F filing for Q1 2025, filed 6 May 2025.